Pith Wave Signal

2 stories tagged #EHA 2026

Newest Most read
  1. J&J's Haematology Chief Discusses Myeloma Therapy Advances at EHA 2026
    health

    J&J's Haematology Chief Discusses Myeloma Therapy Advances at EHA 2026

    Johnson & Johnson's Ester in 't Groen details how T-cell therapies, like bispecifics and CAR-T, are transforming multiple myeloma treatment and extending patient survival.

    last wk. 1 min read
  2. Talquetamab Combinations Set New Standard in Relapsed Myeloma Care
    health

    Talquetamab Combinations Set New Standard in Relapsed Myeloma Care

    Phase 3 MonumenTAL-3 trial data reveals talquetamab regimens sharply cut progression risk in relapsed refractory multiple myeloma, delivering deep and durable responses.

    last mo. 1 min read